Frederick Reimherr
Psychiatry · Salt Lake City, UTNPI 1740259795
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Adlon Therapeutics L.p. at 51.0% of the total. Reporting peaked in 2019 at $15,563 and has fallen 98.0% since, to $304 in 2022. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $252.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Adlon Therapeutics L.p.$9K
- Johnson & Johnson$5K
- Supernus Pharmaceuticals, Inc.$2K
- Janssen Research & Development, LLC$1K
- Sunovion Pharmaceuticals Inc.$142
- Takeda Pharmaceuticals U.S.A., Inc.$134
- plus $669 from 9 others
Across 156 payments — averaging $5965.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$621K
- Boehringer Ingelheim$115K
- Janssen Research & Development, LLC$107K
- AbbVie$38K
- Corcept Therapeutics$18K
- Neurocrine Biosciences, Inc.$13K
- plus $19K from 5 others
What the payments were for
- Consulting fees$7,99544%
- Speaking & faculty fees$5,87532%
- Travel & lodging$2,74215%
- Food & beverage$1,4668%
- Education$1011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Adlon Therapeutics L.p. | 8 | $9,264 |
| Johnson & Johnson | 22 | $4,571 |
| Supernus Pharmaceuticals, Inc. | 1 | $2,025 |
| Janssen Research & Development, LLC | 8 | $1,375 |
| Sunovion Pharmaceuticals Inc. | 3 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $134 |
| AbbVie | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 7 | $98 |
| Biogen | 1 | $95 |
| Neurocrine Biosciences, Inc. | 5 | $94 |
| Teva Pharmaceuticals USA, Inc. | 2 | $77 |
| Janssen Scientific Affairs, LLC | 1 | $70 |
| Ironshore Pharmaceuticals Inc. | 3 | $68 |
| Neuronetics, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADHANSIA XR$9,140
- SPRAVATO$4,164
- INVEGA TRINZA$1,185
How this compares
$18,179 in reported general payments places this provider in the 95th percentile of 231 psychiatry providers in Utah.
Other psychiatry in Salt Lake City
- Noel GardnerSalt Lake City$512K
- Clark JohnsonSalt Lake City$7K
- Julian ThorneSalt Lake City$2K
- Benjamin ShapiroSalt Lake City$1K
- Mark NeumanSalt Lake City$1K
- Marc DavisSalt Lake City$736
- Sajid FaiziSalt Lake City$648
- Kylee JenkinsSalt Lake City$604
- Donna PhilippiSalt Lake City$377
- Joseph ReistetterSalt Lake City$306
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.